OVERWEIGHT OR OBESITY
Clinical trials for OVERWEIGHT OR OBESITY explained in plain language.
Never miss a new study
Get alerted when new OVERWEIGHT OR OBESITY trials appear
Sign up with your email to follow new studies for OVERWEIGHT OR OBESITY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Pfizer launches new drug combo to tackle obesity epidemic
Disease control Not yet recruitingThis study tests two experimental drugs, PF-08653945 and PF-08653944, given alone or together, to help adults with overweight or obesity lose weight. About 872 participants will receive either the drugs or a placebo. The main goal is to see how much weight they lose and if the dr…
Matched conditions: OVERWEIGHT OR OBESITY
Phase: PHASE2 • Sponsor: Pfizer • Aim: Disease control
Last updated May 17, 2026 02:06 UTC
-
New pill could help shed pounds without surgery
Disease control Not yet recruitingThis study tests an oral drug called MDR-001 to help adults with overweight or obesity lose weight over 52 weeks. About 738 participants will take either the drug or a placebo, along with lifestyle changes. The main goal is to see if the drug leads to meaningful weight loss compa…
Matched conditions: OVERWEIGHT OR OBESITY
Phase: PHASE3 • Sponsor: MindRank AI Ltd • Aim: Disease control
Last updated May 14, 2026 12:02 UTC
-
New Weight-Loss shot enters first human safety trial
Disease control Not yet recruitingThis early-stage study tests a single dose of an investigational injection called SYH2082 in 44 healthy adults who are overweight or obese. The main goal is to check if the drug is safe and tolerable, not to treat or cure obesity. Participants will be randomly assigned to receive…
Matched conditions: OVERWEIGHT OR OBESITY
Phase: PHASE1 • Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd. • Aim: Disease control
Last updated May 11, 2026 20:37 UTC
-
AI app aims to boost healthy habits in diabetes and obesity
Knowledge-focused Not yet recruitingThis study will test whether the Thrive AI Health app helps adults aged 40+ with type 2 diabetes or overweight improve their diet, exercise, and sleep. About 20 participants will either use the app or not, and researchers will compare changes in their habits and quality of life o…
Matched conditions: OVERWEIGHT OR OBESITY
Phase: NA • Sponsor: Yale University • Aim: Knowledge-focused
Last updated May 06, 2026 16:02 UTC